Search - tctmd.com

Displaying 681 - 700 of 771

Sort: Relevancy | Date

News Daily News

Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA

Michael O'Riordan

November 28, 2017

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Conference News AHA 2017

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Michael O'Riordan

November 14, 2017

News Daily News

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Michael O'Riordan

October 24, 2017

News Daily News

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Michael O'Riordan

October 19, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Daily News

Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute

Michael O'Riordan

October 10, 2017

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Daily News

Modified Risk Score for ED Chest Pain Patients Reduces Hospital Stays, Lowers Costs

Michael O'Riordan

October 03, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

News Daily News

TAVR in the US: Regional Variations in Numbers, Outcomes

Michael O'Riordan

August 22, 2017

News Daily News

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

Michael O'Riordan

August 17, 2017

Studies Supporting Device Modifications Weak, Often Based on Surrogate Endpoints

News Daily News

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Michael O'Riordan

August 16, 2017

News Daily News

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Michael O'Riordan

August 14, 2017

News Daily News

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Michael O'Riordan

August 02, 2017

Advertisement

Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute

Generic ARBs Linked to Increased Adverse Events

Modified Risk Score for ED Chest Pain Patients Reduces Hospital Stays, Lowers Costs

New Performance and Quality Metrics for STEMI and NSTEMI Care

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

ESC Updates Guidelines for Treating STEMI Patients

Evolocumab Not Cost-Effective at Current List Price

TAVR in the US: Regional Variations in Numbers, Outcomes

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content